We are live on ! Find out more

3,489 hedge funds and large institutions have $222B invested in Merck in 2024 Q3 according to their latest regulatory filings, with 145 funds opening new positions, 1,533 increasing their positions, 1,416 reducing their positions, and 160 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more call options, than puts

Call options by funds: $1.95B | Put options by funds: $1.77B

8% more repeat investments, than reductions

Existing positions increased: 1,533 | Existing positions reduced: 1,416

0.04% more ownership

Funds ownership: 77.22%77.26% (+0.04%)

9% less first-time investments, than exits

New positions opened: 145 | Existing positions closed: 160

2% less funds holding

Funds holding: 3,5443,489 (-55)

8% less capital invested

Capital invested by funds: $242B → $222B (-$20.5B)

41% less funds holding in top 10

Funds holding in top 10: 193114 (-79)

Holders
3,489
Holders Change
-55
Holders Change %
-1.55%
% of All Funds
50.1%
Holding in Top 10
114
Holding in Top 10 Change
-79
Holding in Top 10 Change %
-40.93%
% of All Funds
1.64%
New
145
Increased
1,533
Reduced
1,416
Closed
160
Calls
$1.95B
Puts
$1.77B
Net Calls
+$179M
Net Calls Change
-$149M
Name Holding Trade Value Shares
Change
Change in
Stake
SW
3501
SVB Wealth
Massachusetts
-$14.3M -115,158 Closed
OC
3502
Optimas Capital
Hong Kong
-$14.2M -111,600 Closed
BCIM
3503
Black Creek Investment Management
Ontario, Canada
-$12.6M -102,047 Closed
CCM
3504
Cinctive Capital Management
New York
-$12.5M -100,815 Closed
ACM
3505
Atika Capital Management
New York
-$10.3M -83,000 Closed
SC
3506
Stempoint Capital
New York
-$10.2M -81,508 Closed
QT
3507
Quantbot Technologies
New York
-$9.39M -75,867 Closed
SGH
3508
Sivik Global Healthcare
Connecticut
-$8.15M -65,874 Closed
CIM
3509
Chiron Investment Management
New York
-$6.72M -54,265 Closed
BFM
3510
Boothbay Fund Management
New York
-$6.49M -52,426 Closed
SAM
3511
Simplify Asset Management
Nevada
-$6.35M -51,302 Closed
CF
3512
CNA Financial
Illinois
-$6.19M -50,000 Closed
LC
3513
Loews Corp
New York
-$6.19M -50,000 Closed
PWP
3514
Perfromance Wealth Partners
Illinois
-$6.15M -49,646 Closed
CCA
3515
Catalyst Capital Advisors
New York
-$4.56M -36,800 Closed
GAMH
3516
Greenwoods Asset Management (HK)
Hong Kong
-$4.38M -35,374 Closed
SFC
3517
Strategic Financial Concepts
Texas
-$63.8K -35,057 Closed
FLC
3518
Fifth Lane Capital
Texas
-$3.71M -30,000 Closed
JWM
3519
Jackson Wealth Management
Florida
-$3.42M -27,655 Closed
GCM
3520
Glaxis Capital Management
Florida
-$3.34M -27,000 Closed
PFMU
3521
Privium Fund Management (UK)
United Kingdom
-$3.07M -24,072 Closed
FIA
3522
FNY Investment Advisers
New York
-$2.79M -22,500 Closed
GP
3523
Geneva Partners
Wisconsin
-$2.62M -21,165 Closed
NRD
3524
Nebula Research & Development
New York
-$2.27M -18,344 Closed
MUAMU
3525
Mitsubishi UFJ Asset Management (UK)
United Kingdom
-$1.98M -16,000 Closed

MRK Hedge Fund Activity: Q3 2024 in Review

3,489 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2024, worth a combined $222B — down 8.5% from $242B a quarter earlier.

Sellers outnumbered buyers: 160 funds closed out of MRK and 145 opened new positions — a net loss of 15 holders — while 1,416 trimmed existing stakes and 1,533 added.

The largest buyer was Vanguard Group, adding an estimated $609M. The largest seller was DZ Bank, cutting an estimated $1.3B.

  • 3,489 institutional investors held Merck (MRK) as of Q3 2024, down from 3,544 in Q2 2024.
  • Funds reported $222B of Merck stock for Q3 2024, down 8.5% quarter-over-quarter.
  • 145 funds opened new Merck positions in Q3 2024 and 160 closed out, a net change of -15 holders.
  • The largest Merck buyer in Q3 2024 was Vanguard Group, an estimated $609M added.
  • The largest Merck seller in Q3 2024 was DZ Bank, an estimated $1.3B sold.

Based on aggregated 13F filings for Q3 2024.